| Date | Form | Description | Docs | XBRL | Pages |
| 09/21/12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 09/21/12 | DEF 14A | Definitive proxy statements |
|
25 | |
| 09/18/12 | 8-K | Current report filing |
|
49 | |
| 09/18/12 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act |
|
6 | |
| 09/14/12 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/14/12 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 09/14/12 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
27 |
| 09/11/12 | 8-K | Current report filing |
|
8 | |
| 09/10/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/10/12 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
28 |
Latest News & Events
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Read More...Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Read More...